Dr. Scott Grant, MD

Dr. Grant practices at Fullerton Clinical and Surgical Facility in Fullerton, California.

Dr. Grant's NPI, 1194762310, was assigned on May 31, 2006. Dr. Grant graduated from Stanford University School Of Medicine in 1975. Dr. Grant holds California license G32479.

Dr. Grant's primary practice is Fullerton Clinical and Surgical Facility, at 301 W Bastanchury Rd, Fullerton, CA 92835 in Orange County. The practice phone is (949) 706-2887.

Dr. Grant's primary practice is Fullerton Clinical and Surgical Facility in Fullerton, California. Dmand AI also links Dr. Grant to 1 group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Grant practices. Vendor and product names are available with a free account.

Retina specialist is Dr. Grant's primary specialty in the NPI Registry, under taxonomy code 207WX0107X. Dr. Grant is board certified in ophthalmology by the American Board of Ophthalmology. Dr. Grant is licensed in California.

Dmand AI lists age-related macular degeneration, glaucoma, laser destruction of retinal or choroid lesions, retinal detachment, retinal occlusion, surgical retina and vitreous procedures, vision problems and vitreous eye degeneration among the conditions Dr. Grant treats.

CMS data shows 22,424 Medicare services from Dr. Grant across 9 procedure codes in 2024, for 371 Medicare patients. Medicare paid $988,150 for them. Every service was in an office.

CMS counts 371 Medicare patients who saw Dr. Grant in 2024. The largest group is 75 to 84, with 140 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 13% are also on Medicaid. Their average risk score is 1.86, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Grant's median patient age at 74, with 56% women.

In 2024, Dr. Grant wrote 141 Medicare Part D claims for 41 patients. 60% of them were for generic drugs. CMS names the drug for 65 of them, across 3 drugs with 11 or more claims each, at $1,337 in total drug cost. In 2023, CMS named 80 claims across 4 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Grant for performance year 2024, reported as part of a group. Dr. Grant accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 13 papers to Dr. Grant, published from 2017 to 2022. 2017 was the busiest year, with 4. The most frequent topics are Angiogenesis Inhibitors, Choroidal Neovascularization and Fluorescein Angiography. Dr. Grant's most frequent co-authors are Sean David Adrean, MD, Siyang Chaili, MD and Ash Pirouz, MD.

CMS Open Payments shows 82 general payments to Dr. Grant from 20 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 88% of the total. Apellis Pharmaceuticals, Inc. paid the most, $412.

Dmand AI lists 2 awards for Dr. Grant, most recently CMS Stage 1 EHR in 2013.

Dr. Grant graduated from Stanford University School Of Medicine in 1975. Dr. Grant is a member of AAO.

Dr. Grant is in network with 15 carriers, including Aetna, Blue Cross Blue Shield of Michigan and United Healthcare. Medicare plans come from the most carriers, 10. Check the plan with the practice before a visit.